HCPLive Network

Simple Reminder Form Increases Pneumococcal Vaccination Rate

 
TUESDAY, Jan. 22 (HealthDay News) -- Use of a simple point-of-care paper reminder form is associated with an increase in the percentage of immunosuppressed rheumatology patients who remain up-to-date with their pneumococcal vaccinations, according to research published in the January issue of Arthritis & Rheumatism.

Sonali P. Desai, M.D., M.P.H., of the Brigham and Women's Hospital in Boston, and colleagues evaluated the effects of a quality improvement strategy involving a paper point-of-care reminder form designed to increase the percentage of immunosuppressed patients who kept up-to-date with pneumococcal vaccination, in a rheumatology practice. The cohort included 3,717 patients who were taking immunosuppressive medications (66.0 percent with rheumatoid arthritis; 74.1 percent women).

The researchers found that, in the time period following the intervention, there was a significant increase in the rate of patients who were up-to-date with pneumococcal vaccination for rheumatologists in the intervention (67.6 to 80.0 percent), compared with a stable rate among rheumatologists in the nonintervention control (52.3 to 52.0 percent). Positive predictors of receiving the appropriate vaccinations including having received the intervention (hazard ratio [HR], 3.58), having a primary care physician affiliated with Brigham and Women's Hospital (HR, 1.68), having a diagnosis of diabetes mellitus (HR, 1.57), and being 56 to 65 years of age at baseline (HR, 1.24).

"It is possible to significantly increase vaccination for an important at-risk immunosuppressed patient population through the use of a simple point-of-care reminder," the authors write. "Future efforts should continue to study and test quality improvement methods in order to effect sustained change."

One author disclosed financial ties to the pharmaceutical industry and UpToDate.
 

Abstract
Full Text

Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Even though the active ingredient in marijuana can be associated with memory impairment, it may slow or halt Alzheimer’s disease.
The costs of Medicare associated with Sovaldi (sofosbuvir), an emerging hepatitis C drug, will vary depending on how many people are given the treatment, a blog in Health Affairs found.
For patients with cancer, factors associated with late admission to hospice have been identified, according to a study published online Aug. 25 in the Journal of Clinical Oncology.
Healthcare practices continue to suffer from embezzlement problems. While there is no such thing as a perfect system to prevent embezzlers, there are ways to deter them.
Revised guidelines recommend athletes to drink when they are thirsty and to supplement post-training fluids with “recovery foods.”
Gastroparesis, or delayed gastric emptying, remains misunderstood despite rising prevalence, according to a news release from the International Foundation for Functional Gastrointestinal Disorders (IFFGD), a nonprofit research and education organization addressing issues surrounding gastrointestinal and motility disorders.
The European Commission (EU) has granted Bristol-Myers Squibb’s Daklinza (daclatasvir) approval for an all-oral drug regimen for the treatment of four genotypes of chronic hepatitis C infection.
More Reading